Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.105ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.105ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.105EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.105EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.105ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.105ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.1.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.1.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.1.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.258.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.258.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.258.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.258.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.258.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.307EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.307EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.307ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.307ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.307EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.307EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.307ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.307ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.201EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.201EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.201ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.201ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.201EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.201EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.201ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.201ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
W.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
W.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
W.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
W.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used